277 related articles for article (PubMed ID: 37651054)
1. Application of P7C3 Compounds to Investigating and Treating Acute and Chronic Traumatic Brain Injury.
Sridharan PS; Miller E; Pieper AA
Neurotherapeutics; 2023 Oct; 20(6):1616-1628. PubMed ID: 37651054
[TBL] [Abstract][Full Text] [Related]
2. P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognition.
Vázquez-Rosa E; Shin MK; Dhar M; Chaubey K; Cintrón-Pérez CJ; Tang X; Liao X; Miller E; Koh Y; Barker S; Franke K; Crosby DR; Schroeder R; Emery J; Yin TC; Fujioka H; Reynolds JD; Harper MM; Jain MK; Pieper AA
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27667-27675. PubMed ID: 33087571
[TBL] [Abstract][Full Text] [Related]
3. Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury.
Blaya MO; Wasserman JM; Pieper AA; Sick TJ; Bramlett HM; Dietrich WD
Neuropharmacology; 2019 Feb; 145(Pt B):268-282. PubMed ID: 30236963
[TBL] [Abstract][Full Text] [Related]
4. Reducing acetylated tau is neuroprotective in brain injury.
Shin MK; Vázquez-Rosa E; Koh Y; Dhar M; Chaubey K; Cintrón-Pérez CJ; Barker S; Miller E; Franke K; Noterman MF; Seth D; Allen RS; Motz CT; Rao SR; Skelton LA; Pardue MT; Fliesler SJ; Wang C; Tracy TE; Gan L; Liebl DJ; Savarraj JPJ; Torres GL; Ahnstedt H; McCullough LD; Kitagawa RS; Choi HA; Zhang P; Hou Y; Chiang CW; Li L; Ortiz F; Kilgore JA; Williams NS; Whitehair VC; Gefen T; Flanagan ME; Stamler JS; Jain MK; Kraus A; Cheng F; Reynolds JD; Pieper AA
Cell; 2021 May; 184(10):2715-2732.e23. PubMed ID: 33852912
[TBL] [Abstract][Full Text] [Related]
5. The neuroprotective compound P7C3-A20 promotes neurogenesis and improves cognitive function after ischemic stroke.
Loris ZB; Pieper AA; Dietrich WD
Exp Neurol; 2017 Apr; 290():63-73. PubMed ID: 28077334
[TBL] [Abstract][Full Text] [Related]
6. (-)-P7C3-S243 Protects a Rat Model of Alzheimer's Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia.
Voorhees JR; Remy MT; Cintrón-Pérez CJ; El Rassi E; Khan MZ; Dutca LM; Yin TC; McDaniel LN; Williams NS; Brat DJ; Pieper AA
Biol Psychiatry; 2018 Oct; 84(7):488-498. PubMed ID: 29246437
[TBL] [Abstract][Full Text] [Related]
7. P7C3 neuroprotective chemicals block axonal degeneration and preserve function after traumatic brain injury.
Yin TC; Britt JK; De Jesús-Cortés H; Lu Y; Genova RM; Khan MZ; Voorhees JR; Shao J; Katzman AC; Huntington PJ; Wassink C; McDaniel L; Newell EA; Dutca LM; Naidoo J; Cui H; Bassuk AG; Harper MM; McKnight SL; Ready JM; Pieper AA
Cell Rep; 2014 Sep; 8(6):1731-1740. PubMed ID: 25220467
[TBL] [Abstract][Full Text] [Related]
8. P7C3-A20 Attenuates Microglial Inflammation and Brain Injury after ICH through Activating the NAD
Wu Y; Hu Q; Wu X; Cai YN; Zhang YZ; Wu YX; Zhu G; Luo JN; Cheng HB; Yu JG; Wang XL; Gao L; Gao GD
Oxid Med Cell Longev; 2023; 2023():7857760. PubMed ID: 36819779
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury.
Blaya MO; Bramlett HM; Naidoo J; Pieper AA; Dietrich WD
J Neurotrauma; 2014 Mar; 31(5):476-86. PubMed ID: 24070637
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective Efficacy of an Aminopropyl Carbazole Derivative P7C3-A20 in Ischemic Stroke.
Wang SN; Xu TY; Wang X; Guan YF; Zhang SL; Wang P; Miao CY
CNS Neurosci Ther; 2016 Sep; 22(9):782-8. PubMed ID: 27333812
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective efficacy of P7C3 compounds in primate hippocampus.
Bauman MD; Schumann CM; Carlson EL; Taylor SL; Vázquez-Rosa E; Cintrón-Pérez CJ; Shin MK; Williams NS; Pieper AA
Transl Psychiatry; 2018 Sep; 8(1):202. PubMed ID: 30258178
[TBL] [Abstract][Full Text] [Related]
12. Maternal P7C3-A20 Treatment Protects Offspring from Neuropsychiatric Sequelae of Prenatal Stress.
Schroeder R; Sridharan P; Nguyen L; Loren A; Williams NS; Kettimuthu KP; Cintrón-Pérez CJ; Vázquez-Rosa E; Pieper AA; Stevens HE
Antioxid Redox Signal; 2021 Sep; 35(7):511-530. PubMed ID: 33501899
[No Abstract] [Full Text] [Related]
13. Early detection of subclinical visual damage after blast-mediated TBI enables prevention of chronic visual deficit by treatment with P7C3-S243.
Dutca LM; Stasheff SF; Hedberg-Buenz A; Rudd DS; Batra N; Blodi FR; Yorek MS; Yin T; Shankar M; Herlein JA; Naidoo J; Morlock L; Williams N; Kardon RH; Anderson MG; Pieper AA; Harper MM
Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8330-41. PubMed ID: 25468886
[TBL] [Abstract][Full Text] [Related]
14. Seizures are a druggable mechanistic link between TBI and subsequent tauopathy.
Alyenbaawi H; Kanyo R; Locskai LF; Kamali-Jamil R; DuVal MG; Bai Q; Wille H; Burton EA; Allison WT
Elife; 2021 Feb; 10():. PubMed ID: 33527898
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of death-associated protein kinase 1 attenuates cis P-tau and neurodegeneration in traumatic brain injury.
Kim N; Wang B; Koikawa K; Nezu Y; Qiu C; Lee TH; Zhou XZ
Prog Neurobiol; 2021 Aug; 203():102072. PubMed ID: 33979671
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective Effects of 1-(3,6-Dibromo-carbazol-9-yl)-3-Phenylamino-Propan-2-Ol in Diabetic Hearts via Nicotinamide Phosphoribosyltransferase Activation.
Tur J; Badole SL; Manickam R; Chapalamadugu KC; Xuan W; Guida W; Crews JJ; Bisht KS; Tipparaju SM
J Pharmacol Exp Ther; 2022 Aug; 382(2):233-245. PubMed ID: 35680376
[TBL] [Abstract][Full Text] [Related]
17. P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage.
Wang G; Han T; Nijhawan D; Theodoropoulos P; Naidoo J; Yadavalli S; Mirzaei H; Pieper AA; Ready JM; McKnight SL
Cell; 2014 Sep; 158(6):1324-1334. PubMed ID: 25215490
[TBL] [Abstract][Full Text] [Related]
18. Active immunotherapy against pathogenic Cis pT231-tau suppresses neurodegeneration in traumatic brain injury mouse models.
Alipour M; Tebianian M; Tofigh N; Taheri RS; Mousavi SA; Naseri A; Ahmadi A; Munawar N; Shahpasand K
Neuropeptides; 2022 Dec; 96():102285. PubMed ID: 36087426
[TBL] [Abstract][Full Text] [Related]
19. An update on the association between traumatic brain injury and Alzheimer's disease: Focus on Tau pathology and synaptic dysfunction.
Li L; Liang J; Fu H
Neurosci Biobehav Rev; 2021 Jan; 120():372-386. PubMed ID: 33171143
[TBL] [Abstract][Full Text] [Related]
20. Interferon-β Plays a Detrimental Role in Experimental Traumatic Brain Injury by Enhancing Neuroinflammation That Drives Chronic Neurodegeneration.
Barrett JP; Henry RJ; Shirey KA; Doran SJ; Makarevich OD; Ritzel RM; Meadows VA; Vogel SN; Faden AI; Stoica BA; Loane DJ
J Neurosci; 2020 Mar; 40(11):2357-2370. PubMed ID: 32029532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
